Annual CFI
$400.00 K
+$1.06 M+160.98%
December 31, 2023
Summary
- As of February 12, 2025, PBLA annual cash flow from investing activities is $400.00 thousand, with the most recent change of +$1.06 million (+160.98%) on December 31, 2023.
- During the last 3 years, PBLA annual CFI has risen by +$400.00 thousand (+100.00%).
- PBLA annual CFI is now -20.00% below its all-time high of $500.00 thousand, reached on December 31, 2015.
Performance
PBLA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
-$775.00 K-100.00%
September 30, 2024
Summary
- As of February 12, 2025, PBLA quarterly cash flow from investing activities is $0.00, with the most recent change of -$775.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, PBLA quarterly CFI has stayed the same.
- PBLA quarterly CFI is now -100.00% below its all-time high of $775.00 thousand, reached on June 30, 2024.
Performance
PBLA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$775.00 K
-$400.00 K-34.04%
September 30, 2024
Summary
- As of February 12, 2025, PBLA TTM cash flow from investing activities is $775.00 thousand, with the most recent change of -$400.00 thousand (-34.04%) on September 30, 2024.
- Over the past year, PBLA TTM CFI has increased by +$375.00 thousand (+93.75%).
- PBLA TTM CFI is now -34.04% below its all-time high of $1.18 million, reached on June 30, 2024.
Performance
PBLA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PBLA Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +161.0% | 0.0% | +93.8% |
3 y3 years | +100.0% | - | - |
5 y5 years | - | - | - |
PBLA Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +161.0% | -100.0% | +100.0% | -34.0% | +218.1% |
5 y | 5-year | at high | +161.0% | -100.0% | +100.0% | -34.0% | +218.1% |
alltime | all time | -20.0% | +161.0% | -100.0% | +100.0% | -34.0% | +218.1% |
Panbela Therapeutics Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $0.00(-100.0%) | $775.00 K(-34.0%) |
Jun 2024 | - | $775.00 K(>+9900.0%) | $1.18 M(+193.8%) |
Dec 2023 | $400.00 K(-161.0%) | $0.00(-100.0%) | $400.00 K(0.0%) |
Sep 2023 | - | $400.00 K(>+9900.0%) | $400.00 K(<-9900.0%) |
Jun 2023 | - | $0.00(0.0%) | -$1000.00(-99.8%) |
Dec 2022 | -$656.00 K(<-9900.0%) | $0.00(-100.0%) | -$656.00 K(0.0%) |
Sep 2022 | - | -$1000.00(-99.8%) | -$656.00 K(+0.2%) |
Jun 2022 | - | -$655.00 K(<-9900.0%) | -$655.00 K(<-9900.0%) |
Dec 2021 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2021 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2020 | $0.00(-100.0%) | - | - |
Dec 2015 | $500.00 K | $0.00(-100.0%) | $500.00 K(<-9900.0%) |
Sep 2015 | - | $500.00 K(>+9900.0%) | -$1000.00(-99.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2015 | - | $0.00(-100.0%) | -$536.60 K(+7.1%) |
Dec 2014 | -$501.00 K(+9723.5%) | -$501.00 K(+1307.3%) | -$501.00 K(+253.3%) |
Sep 2014 | - | -$35.60 K(-195.2%) | -$141.80 K(+205.6%) |
Jun 2014 | - | $37.40 K(-2177.8%) | -$46.40 K(+12.9%) |
Mar 2014 | - | -$1800.00(-98.7%) | -$41.10 K(+705.9%) |
Dec 2013 | -$5100.00(-126.7%) | -$141.80 K(-337.1%) | -$5100.00(-103.7%) |
Sep 2013 | - | $59.80 K(+40.0%) | $139.50 K(+80.9%) |
Jun 2013 | - | $42.70 K(+24.9%) | $77.10 K(+125.4%) |
Mar 2013 | - | $34.20 K(+1121.4%) | $34.20 K(+79.1%) |
Dec 2012 | $19.10 K(-301.1%) | $2800.00(-207.7%) | $19.10 K(+17.2%) |
Sep 2012 | - | -$2600.00(+1200.0%) | $16.30 K(-13.8%) |
Jun 2012 | - | -$200.00(-101.0%) | $18.90 K(-1.0%) |
Mar 2012 | - | $19.10 K | $19.10 K |
Dec 2011 | -$9500.00 | - | - |
FAQ
- What is Panbela Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Panbela Therapeutics?
- What is Panbela Therapeutics annual CFI year-on-year change?
- What is Panbela Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly CFI year-on-year change?
- What is Panbela Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Panbela Therapeutics?
- What is Panbela Therapeutics TTM CFI year-on-year change?
What is Panbela Therapeutics annual cash flow from investing activities?
The current annual CFI of PBLA is $400.00 K
What is the all time high annual CFI for Panbela Therapeutics?
Panbela Therapeutics all-time high annual cash flow from investing activities is $500.00 K
What is Panbela Therapeutics annual CFI year-on-year change?
Over the past year, PBLA annual cash flow from investing activities has changed by +$1.06 M (+160.98%)
What is Panbela Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PBLA is $0.00
What is the all time high quarterly CFI for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly cash flow from investing activities is $775.00 K
What is Panbela Therapeutics quarterly CFI year-on-year change?
Over the past year, PBLA quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Panbela Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PBLA is $775.00 K
What is the all time high TTM CFI for Panbela Therapeutics?
Panbela Therapeutics all-time high TTM cash flow from investing activities is $1.18 M
What is Panbela Therapeutics TTM CFI year-on-year change?
Over the past year, PBLA TTM cash flow from investing activities has changed by +$375.00 K (+93.75%)